Vitality Biopharma Retains DelMorgan & Co. to Explore Strategic Alternatives
September 25, 2020, 4:15 pm
(GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”), a drug development company dedicated to unlocking the unique therapeutic powers of cannabinoids, today announced that it has retained DelMorgan & Co.
